# Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pioglitazone-for-diabetes-prevention-in-impaired-glucose-tolerance/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ralph A. DeFronzo,Devjit Tripathy,Dawn C. Schwenke,MaryAnn Banerji,George A. Bray,Thomas A. Buchanan,Stephen Clement,Robert R. Henry,Howard N. Hodis,Abbas E. Kitabchi,Wendy J. Mack,Sunder Mudaliar,Robert E. Ratner,Ken Williams,Frankie B. Stentz,Nicolas Musi,Peter D. Reaven |
| Citations | 745 |
| DOI | 10.1056/nejmoa1010949 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1010949?articleTools=true |
| OpenAlex ID | https://openalex.org/W2131330057 |
| PMID | 21428766 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Peter D. Reaven](https://scholariq.org/researchers/peter-d-reaven/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Paper topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.